PU.1 interaction with p50 promotes microglial-mediated inflammation in secondary spinal cord injury in SCI rats

References

• Kokoglu C, Delen E, Arslantas A, et al. Therapeutic efficacy of tadalafil and eriythropoietin in experimental spinal cord injury. TJTES. 2016;22(6):521–525.
   Google Scholar
• Sawada M, Kato K, Kunieda T, et al. Function of the nucleus accumbens in motor control during recovery after spinal cord injury. Science (New York, NY). 2015;350(6256):98–101.
   Google Scholar
• Kim DK, Kweon KJ, Kim P, et al. Ginsenoside Rg3 improves recovery from spinal cord injury in rats via suppression of neuronal apoptosis, pro-inflammatory mediators, and microglial activation. Molecules (Basel, Switzerland). 2017;22(1):122.
   PubMed Web of Science ®Google Scholar
• Kingwell K. A new approach to respiratory recovery after spinal cord injury?Nat Rev Neurol. 2011;7(9):473.
   PubMedGoogle Scholar
• Jiang X, Yu M, Ou Y, et al. Downregulation of USP4 promotes activation of microglia and subsequent neuronal inflammation in rat spinal cord after injury. Neurochem Res. 2017;42(11):3245–3253.
   PubMed Web of Science ®Google Scholar
• Cartier N, Lewis CA, Zhang R, et al. The role of microglia in human disease: therapeutic tool or target?Acta Neuropathol. 2014;128(3):363–380.
   PubMed Web of Science ®Google Scholar
• Yoshino O, Matsuno H, Nakamura H, et al. The role of Fas-mediated apoptosis after traumatic spinal cord injury. Spine. 2004;29(13):1394–1404.
   PubMed Web of Science ®Google Scholar
• Nakajima K, Kohsaka S. Microglia: neuroprotective and neurotrophic cells in the central nervous system. Curr Drug Targets Cardiovasc Haematol Disord. 2004;4(1):65–84.
   PubMedGoogle Scholar
• Smith JA, Das A, Ray SK, et al. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull. 2012;87(1):10–20.
   PubMed Web of Science ®Google Scholar
• Chopin M, Seillet C, Chevrier S, et al. Langerhans cells are generated by two distinct PU.1-dependent transcriptional networks. J Exp Med. 2013;210(13):2967–2980.
   PubMed Web of Science ®Google Scholar
• Karpurapu M, Wang X, Deng J, et al. Functional PU.1 in macrophages has a pivotal role in NF-kappaB activation and neutrophilic lung inflammation during endotoxemia. Blood. 2011;118(19):5255–5266.
   PubMed Web of Science ®Google Scholar
• Goldmann T, Wieghofer P, Jordao MJ, et al. Origin, fate and dynamics of macrophages at central nervous system interfaces. Nat Immunol. 2016;17(7):797–805.
   PubMed Web of Science ®Google Scholar
• Smith AM, Gibbons HM, Oldfield RL, et al. The transcription factor PU.1 is critical for viability and function of human brain microglia. Glia. 2013;61(6):929–942.
   PubMed Web of Science ®Google Scholar
• Zhang J, Cui Z, Feng G, et al. RBM5 and p53 expression after rat spinal cord injury: implications for neuronal apoptosis. Int J Biochem Cell Biol. 2015;60:43–52.
   PubMed Web of Science ®Google Scholar
• Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 1995;12(1):1–21.
   PubMed Web of Science ®Google Scholar
• Adriaansen JJ, Ruijs LE, van Koppenhagen CF, et al. Secondary health conditions and quality of life in persons living with spinal cord injury for at least ten years. J Rehabil Med. 2016;48(10):853–860.
   PubMed Web of Science ®Google Scholar
• Stein DM, Pineda JA, Roddy V, et al. Emergency Neurological Life Support: Traumatic Spine Injury. Neurocrit Care. 2015;23 (Suppl 2):S155–S164.
   PubMed Web of Science ®Google Scholar
• Wu C, Cui Z, Liu Y, et al. The importance of EHD1 in neurite outgrowth contributing to the functional recovery after spinal cord injury. Int J Develop Neurosci. 2016;52:24–32.
   PubMed Web of Science ®Google Scholar
• Harms AS, Lee JK, Nguyen TA, et al. Regulation of microglia effector functions by tumor necrosis factor signaling. Glia. 2012;60(2):189–202.
   PubMed Web of Science ®Google Scholar
• Magni P, Ruscica M, Dozio E, et al. Parthenolide inhibits the LPS-induced secretion of IL-6 and TNF-alpha and NF-kappaB nuclear translocation in BV-2 microglia. Phytother Res. 2012;26(9):1405–1409.
   PubMed Web of Science ®Google Scholar
• Hoppenot D, Malakauskas K, Lavinskiene S, et al. p-STAT6, PU.1, and NF-kappaB are involved in allergen-induced late-phase airway inflammation in asthma patients. BMC Pulm Med. 2015;15(1):122.
   PubMed Web of Science ®Google Scholar
• Wang M, Liu Z, Liu C, et al. PU.1 is involved in the immune response to Aspergillus fumigatus through upregulating Dectin-1 expression. BMC Infect Dis. 2016;16:297.
   PubMed Web of Science ®Google Scholar
• Ghosh M, Aguirre V, Wai K, et al. The interplay between cyclic AMP, MAPK, and NF-kappaB pathways in response to proinflammatory signals in microglia. BioMed Res Int. 2015;2015:308461.
   PubMed Web of Science ®Google Scholar
• Liu G, Fan G, Guo G, et al. FK506 attenuates the inflammation in rat spinal cord injury by inhibiting the activation of NF-kappaB in microglia cells. Cell Mol Neurobiol. 2017;37(5):843–855.
   PubMed Web of Science ®Google Scholar
• Pamukcu B, Lip GY, Shantsila E. The nuclear factor–kappa B pathway in atherosclerosis: a potential therapeutic target for atherothrombotic vascular disease. Thromb Res. 2011;128(2):117–123.
   PubMed Web of Science ®Google Scholar
• Pordanjani SM, Hosseinimehr SJ. The role of NF-kB inhibitors in cell response to radiation. Curr Med Chem. 2016;23(34):3951–3963.
   PubMed Web of Science ®Google Scholar
• Kaltschmidt B, Kaltschmidt C. NF-kappaB in the nervous system. Cold Spring Harbor Perspect Biol. 2009;1(3):a001271.
   PubMed Web of Science ®Google Scholar
• Lin L, DeMartino GN, Greene WC. Cotranslational dimerization of the Rel homology domain of NF-kappaB1 generates p50-p105 heterodimers and is required for effective p50 production. EMBO J. 2000;19(17):4712–4722.
   PubMed Web of Science ®Google Scholar
• Meffert MK, Chang JM, Wiltgen BJ, et al. NF-kappa B functions in synaptic signaling and behavior. Nat Neurosci. 2003;6(10):1072–1078.
   PubMed Web of Science ®Google Scholar
• Okamoto T, Sanda T, Asamitsu K. NF-kappa B signaling and carcinogenesis. Curr Pharm Des. 2007;13(5):447–462.
   PubMed Web of Science ®Google Scholar
• Pongubala JM, Atchison ML. PU.1 can participate in an active enhancer complex without its transcriptional activation domain. Proc Natl Aacd Sci U S A. 1997;94(1):127–132.
   PubMed Web of Science ®Google Scholar
• Hagemeier C, Bannister AJ, Cook A, et al. The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc Natl Acad Sci USA. 1993;90(4):1580–1584.
   PubMed Web of Science ®Google Scholar
• Klemsz MJ, McKercher SR, Celada A, et al. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell. 1990;61(1):113–124.
   PubMed Web of Science ®Google Scholar
• Lin L, Ghosh S. A glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunit. Mol Cell Biol. 1996;16(5):2248–2254.
   PubMed Web of Science ®Google Scholar
• Friedman AD. C/EBPalpha induces PU.1 and interacts with AP-1 and NF-kappaB to regulate myeloid development. Blood Cells Mol Dis. 2007;39(3):340–343.
   PubMed Web of Science ®Google Scholar